Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Amerisource, Sarepta, BofA, Ebay, Lululemon, Juniper

Tue, 19th Mar 2013 13:21

March 19 (Reuters) - Some U.S. stocks to watch on Tuesday:

(For more market insights, including options activity, click on ; for The Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/faq23t)

FUTURES GAIN BEFORE DATA, FOCUS SHIFTS FROM CYPRUS

U.S. stock index futures edged up on Tuesday, after two daysof declines, as investors' focus shifted away from developmentsin Cyprus that may lead the country into default.

S&P 500 futures added 3.7 points. Dow Jonesindustrial average futures added 20 points and Nasdaq 100futures gained 9 points.

** AMERISOURCEBERGEN, Monday close $51.27, up 6 pctpremarket

** WALGREEN CO, Monday close $42.43, up 2 pctpremarket

** CARDINAL HEALTH INC, Monday close $46.13, down 5pct premarket

Drug distributor AmerisourceBergen signed a 10-yeardistribution deal with Walgreen Co and partner Alliance BootsABN.UL that it said would deliver $28 billion in incrementalrevenue in fiscal 2014 and give the pharmacy chains the right toacquire up to 23 percent of the company. Shares ofAmerisourceBergen rival, Cardinal Health, fell in premarkettrade on news of the contract.

** AFFYMAX INC, Monday close $2.92, down 58 pctpremarket

The drugmaker said on Monday that it was considering sellingitself or filing for bankruptcy among a range of alternatives,as it struggles to stay afloat following the recent recall ofits sole commercial product, anemia drug Omontys.

** HARVEST NATURAL RESOURCES INC, Monday close$5.49, down 40 pct premarket

The oil and gas producer said it had identified someaccounting errors and it might have to restate results for someperiods in the last three years.

Harvest Natural also estimated a full-year loss of about$9.6 million, or 26 cents per share, for 2012.

** MER TELEMANAGEMENT SOLUTIONS LTD, Monday close$5.02, down 35 pct premarket

The company, which provides products and services to managetelecommunications expenses, said one of its customers, SimpleMobile, intends to migrate its hosted billing services to itsown platform.

MTS had last year entered into a one-year agreement with thecompany, a part of TracFone, to provide hosted billing servicesfor minimum monthly payments of $300,000 for 2013. "It isunlikely that we will receive significant revenues from TracFonein 2014," MTS said in a release.

** GMX RESOURCES INC, Monday close $4, down 12.5pct premarket

The oil and gas producer reiterated that it may seekbankruptcy protection if it is not able to reach a consensualalternative for restructuring its balance sheet. The companyalso said it had not been able to file its annual report as ithad been focused on discussions with lenders and findingfinancing alternatives.

** NPS PHARMACEUTICALS INC, Monday close $9.04, up10 pct premarket

NPS has regained full worldwide rights to a pair of drugsfrom Japan's Takeda Pharmaceutical Co in exchange for$50 million in NPS common shares, the companies announced onTuesday.

Under the deal, NPS will have worldwide rights to developand sell teduglutide, a treatment for a rare condition calledshort bowel syndrome, sold in Europe as Revestive and in theUnited States as Gattex, and for an osteoporosis drug sold inEurope under the brand name Preotact.

** DSW INC, Monday close $67.05, down 8 pctpremarket

The footwear retailer said it was off to a slow start in2013 as it experienced weak sales trends in the first six weeksof the year, prompting it to forecast flat same-store sales forthe first half of the year. The company also postedfourth-quarter results that missed Wall Street expectations.

** LULULEMON ATHLETICA INC , Monday close$65.90, down 8 pct premarket

The Canadian company is pulling shipments of unexpectedlysheer women's yoga pants from its stores, in a move the athleticclothing maker said would hurt its bottom line.

** HOSPITALITY PROPERTIES TRUST, Monday close$27.19, down 7 pct premarket

The owner of hotels and travel centers said it was raisingmoney through an offering of 10 million shares to pay down debt.

** SKULLCANDY INC, Monday close $5.33, up 6 pctpremarket

The maker of trendy headphones named the head of Nike Inc's Nike+ Digital Sport as its chief executive, as it dealswith the loss of a major customer and looks to rein in costsrelated to international expansion.

** CRESTWOOD MIDSTREAM PARTNERS LP, Monday close$24.85, down 4.6 pct premarket

The company, which transports natural gas and relatedliquids, said it has started a public offering of 4.5 millioncommon units and will use the proceeds to repay debt.

** HOLLY ENERGY PARTNERS LP, Monday close $42.28,down 4 pct premarket

The company, which operates petroleum product and crudepipelines, said it plans to offer 1.87 million common units anduse the proceeds to repay debt.

** SAREPTA THERAPEUTICS INC, Monday close $33.03,up 4 pct premarket

Deutsche Bank analyst Robyn Karnauskas initiated coverage onthe company with a "buy" rating, saying its experimental drug totreat Duchenne muscular dystrophy, a genetic disorder thatcauses progressive muscle loss, is likely to get U.S. approvalby mid-2015.

"We see eteplirsen as having a better safety profile versusits competitor Drisapersen that will allow it to take majorityshare," Karnauskas wrote in a note to clients. Drisapersen isbeing tested by GlasxoSmithKline Plc in a late-stagetrial, while eteplirsen is in a mid-stage study.

** JUNIPER NETWORKS INC, Monday close $20.21, down3.5 pct premarket

Goldman Sachs downgraded the network equipment maker to"sell" from "neutral", saying Alcatel-Lucent and Cisco SystemsInc are expected to take market share from Juniper.

"We see continued share loss to Palo Alto Networks and others, as Juniper's products still have certain gapscompared to the competition, such as the reporting features,"analyst Simona Jankowski wrote in a note.

The company's expected transition to a software model mayhave a cannibalistic effect as Juniper begins to sell softwarelicenses on an as-needed basis as opposed to the traditionalmodel of up-front hardware sales, the note said. The brokeragealso cut its price target on the stock to $17 from $21.

** 8X8 INC, Monday close $6.90, up 3.2 pctpremarket

The Internet telephone company launched a new softphone appintegrating Internet phone calls with one-on-one video calling,web and video conferencing, and visual voicemail.

** EBAY INC, Monday close $50.11, up 1.8 pctpremarket

Cantor Fitzgerald upgraded the e-commerce company's stock to "buy" from "hold", saying it expects the number of activeusers of its online marketplace to increase as it adds brandedretailers and other features.

"We expect to see a positive impact on growth ininternational markets as many of these changes are rolled outoutside the U.S.," analyst Youssef Squali said in a note. Theimpact of the new "digital wallet" fee on the company's PayPalbusiness was also likely to be "manageable", Squali added.

** ELECTRONIC ARTS, Monday close $18.71, up 1.5 pctpremarket

The company behind the "Sims" and "Medal of Honor"franchises said on Monday Chief Executive John Riccitiello hadresigned after six years at the helm of the video gamespublisher.

** BANK OF AMERICA CORP, Monday close $12.56, up 1.4pct premarket

Bank of America's shares recovered slightly after Cyprus'sgovernment proposed on Tuesday to spare small savers from a taxon bank deposits, in a last-minute attempt to win parliamentarybacking for an international bailout and avoid a default and abanking collapse.

** CHARTER COMMUNICATIONS INC, Monday close 98.04,down 1 pct premarket

** LIBERTY MEDIA CORP, Monday close $110.66

Liberty Media Corp will buy a 27.3 percent stake in cableoperator Charter Communications Inc for about $2.62 billion.Liberty will pay $95.50 for each Charter share, a discount of2.6 percent to Charter's Monday close of $98.04.

** HUNTSMAN CORP, Monday close $19.26, up 1 pctpremarket

The chemical maker said its facilities in Port Neches,Texas, which were under maintenance, are now operating at normalrates. The company added that its first-quarter EBITDA would behurt by $10 million as a result of delays in maintenanceactivity.

** TWO HARBORS INVESTMENT CORP, Monday close $13.87,down 1 pct premarket

The REIT, which invests in residential mortgage-backedsecurities and residential mortgage loans, said it plans tooffer 50 million shares to raise funds for acquisitions.

** CHESAPEAKE ENERGY CORP, Monday close $22.17, down1 pct premarket

The second-largest U.S. natural gas company gave moredetails about its plan to raise $2.3 billion by selling seniornotes. It will use the proceeds to buy some of its debt due 2013and 2018.

** INTERSECTIONS INC, Monday close $11.05, down 14pct after market

The provider of indentity theft protection said on Mondayits full-year revenue will fall as much as 15 percent asregulatory scrutiny causes financial services companies to pullback on marketing its products.

** FUTUREFUEL CORP, Monday close $13.66, down 9 pctafter market

The chemicals and biofuels maker posted a fourth-quarterprofit that missed analysts' estimates as revenue from two ofits largest customers fell due to the expiration of a$1-per-gallon tax credit for biodiesel.

** USA MOBILITY INC, Monday close $12.74, down 5pct after market

The paging and wireless services provider on Monday delayedthe reporting of its fourth-quarter and full-year 2012 results,citing a "material weakness" related to its software revenuerecognition process.

The company did not provide a new date for reporting itsfourth-quarter and full-year results.

** CHIQUITA BRANDS INTERNATIONAL INC, Monday close$7.39, up 3 pct after market

The fruit and vegetable distributor's Chief Executive, EdLonergan, revealed in a regulatory filing that he had acquired50,800 shares of the company for about $367,000. The priceimplies an average purchase value of $7.22 per share. (Compiled by Pallavi Ail in Bangalore; Editing by SreejirajEluvangal)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.